INCREMENTAL ASSUMPTION AGREEMENTIncremental Assumption Agreement • August 12th, 2021 • Elanco Animal Health Inc • Pharmaceutical preparations • New York
THIS INCREMENTAL ASSUMPTION AGREEMENT (this “Agreement”) dated and effective as of August 12, 2021 (the “Effective Date”), is among ELANCO ANIMAL HEALTH INCORPORATED, an Indiana corporation (the “Company”), ELANCO US INC., a Delaware corporation (together with the Company, collectively, the “Borrowers” and each, individually, a “Borrower”), THE SUBSIDIARY LOAN PARTIES party hereto, FARM CREDIT MID-AMERICA, PCA (“FCMA”) and each other person (if any) party hereto as a 2021 Incremental Term Lender (collectively, the “2021 Incremental Term Lenders” and each, individually, a “2021 Incremental Term Lender”) and GOLDMAN SACHS BANK USA (“Goldman Sachs”), as term facility agent (in such capacity, the “Term Loan Administrative Agent”).
